SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,802.75 |
| Enterprise Value ($M) | 1,321.60 |
| Book Value ($M) | 411.80 |
| Book Value / Share | 4.58 |
| Price / Book | 4.38 |
| NCAV ($M) | 411.16 |
| NCAV / Share | 4.57 |
| Price / NCAV | 4.38 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.56 |
| Return on Assets (ROA) | -0.43 |
| Return on Equity (ROE) | -0.53 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.17 |
| Current Ratio | 8.17 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 487.82 |
| Assets | 488.46 |
| Liabilities | 76.66 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 14.09 |
| Operating Income | -182.97 |
| Net Income | -176.94 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -141.22 |
| Cash from Investing | -0.02 |
| Cash from Financing | 8.91 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | BCLS II Investco, LP | 6.00 | 0.00 | |
| 13D/A | Frazier Life Sciences X, L.P. | 14.20 | 0.00 | |
| 13G/A | Viking Global Investors Lp | 9.70 | 22.99 | |
| 13G/A | Ra Capital Management, L.p. | 9.90 | -12.17 | |
| 13G/A | Morningside Venture Investments Ltd | 4.93 | ||
| 13D/A | Forbion Capital Fund IV Cooperatief U.A. | 14.50 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 16,516 | 142,857 | 11.56 | |
| 18,294 | 178,523 | 10.25 | |
| 28,281 | 244,051 | 11.59 | |
| 22,199 | 134,715 | 16.48 | |
| 28,151 | 107,664 | 26.15 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MRUS – Merus N.V. | MURA – Mural Oncology plc |
| NAII – Natural Alternatives International, Inc. | NGNE – Neurogene Inc. |
| NKGN – NKGen Biotech, Inc. |
Financial data and stock pages provided by
Fintel.io